Gene · 1457
Papers3,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37509370 | PubTator, text mining | PubMed |
| A comprehensive protein interaction map and druggability investigation prioritized dengue virus NS1 protein as promising therapeutic candidate. | PLoS One | 2023 | 37498862 | PubTator, text mining | PubMed |
| Inherited CSNK2A1 variants in families with Okur-Chung neurodevelopmental syndrome. | Clin Genet | 2023 | 37491870 | PubTator, text mining | PubMed |
| Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B. | J Med Chem | 2023 | 37487467 | PubTator, text mining | PubMed |
| Rapid phosphorylation of glucose-6-phosphate dehydrogenase by casein kinase 2 sustains redox homeostasis under ionizing radiation. | Redox Biol | 2023 | 37478541 | PubTator, text mining | PubMed |
| Identification of mitochondrial-related genes as potential biomarkers for the subtyping and prediction of Alzheimer's disease. | Front Mol Neurosci | 2023 | 37470054 | PubTator, text mining | PubMed |
| Concatenation of molecular docking and dynamics simulation of human papillomavirus type 16 E7 oncoprotein targeted ligands: In quest of cervical cancer's treatment. | An Acad Bras Cienc | 2023 | 37466536 | PubTator, text mining | PubMed |
| Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. | Noncoding RNA Res | 2023 | 37434946 | PubTator, text mining | PubMed |
| Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. | Noncoding RNA Res | 2023 | 37416747 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
| Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer. | Genes Dis | 2023 | 37396515 | PubTator, text mining | PubMed |
| P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis. | Exp Cell Res | 2023 | 37391010 | PubTator, text mining | PubMed |
| DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. | Cancer Lett | 2023 | 37390887 | PubTator, text mining | PubMed |
| Molecular mimicry and autoimmunity in the time of COVID-19. | J Autoimmun | 2023 | 37390745 | PubTator, text mining | PubMed |
| Alternative polyadenylation factor CPSF6 regulates temperature compensation of the mammalian circadian clock. | PLoS Biol | 2023 | 37379316 | PubTator, text mining | PubMed |
| The Role of Erythrocyte Membrane Protein Band 4.1-like 3 in Idiopathic Pulmonary Fibrosis. | Int J Mol Sci | 2023 | 37373330 | PubTator, text mining | PubMed |
| Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach. | Cancers (Basel) | 2023 | 37370767 | PubTator, text mining | PubMed |
| An optogenetic-phosphoproteomic study reveals dynamic Akt1 signaling profiles in endothelial cells. | Nat Commun | 2023 | 37365174 | PubTator, text mining | PubMed |
| New oncogenic functions of LINE1 retroelement as a ceRNA for tumor suppressive microRNA miR-126 on ENPP5. | PLoS One | 2023 | 37352273 | PubTator, text mining | PubMed |
| lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression level. | Aging (Albany NY) | 2023 | 37348024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1457/papers?page=9